GENEO Capital Entrepreneur is a French private equity firm founded in 2019, managing an evergreen fund with €740 million under management, dedicated to supporting the long-term growth and transfer of SMEs and ETIs through tailor-made…Read full bio
2 funds tracked, 29 portfolio companies (26 active · 3 realized). Verified weekly from public filings and deal announcements.
GENEO Capital Entrepreneur is a French private equity firm with €740 million of assets under management as of December 2024, founded in 2019 and headquartered in Paris. The firm manages an evergreen fund dedicated to supporting the long-term growth and transfer of French SMEs, distinguishing the platform with the evergreen permanent capital structure aligned with patient capital and management transition scenarios.
GENEO targets French SMEs and mid-cap companies seeking patient capital for growth, succession or management buyout scenarios, with the evergreen fund structure enabling long-duration positions unconstrained by traditional fund cycles. Sector focus spans Business Services, Industrials and Healthcare, with the platform emphasising operational partnership and patient capital deployment alongside owner-operator management teams.
Recent realised exits include Convictions RH (business services, 2025), Human and Work (business services, 2024) and Zurflüh-Feller (industrials, 2022), reflecting selective distribution across the evergreen portfolio. The platform tracks 2 funds and 26 active portfolio companies across the long-duration French SME programme. Detailed buyer names and multiple data available on Pro at €49/month.
Other private equity firms tracked on GP Intel.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in